4.7025
+4.3695
+(1,312.16%)
At close: January 24 at 4:00:01 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
4,299.8400
19,552.9250
26,719.1330
4,096.8910
Total Liabilities Net Minority Interest
2,343.5040
3,995.9730
4,413.2130
681.2500
Total Equity Gross Minority Interest
1,956.3360
15,556.9520
22,305.9200
3,415.6410
Total Capitalization
1,956.3360
14,671.9240
22,305.9200
3,415.6410
Preferred Stock Equity
--
--
--
32.7540
Common Stock Equity
1,956.3360
14,671.9240
22,305.9200
3,382.8870
Capital Lease Obligations
--
63.8200
176.3030
--
Net Tangible Assets
1,745.4040
14,292.2380
13,794.3580
1,597.9200
Working Capital
1,238.0270
14,435.9640
14,999.6070
1,597.9200
Invested Capital
1,956.3360
14,671.9240
22,305.9200
3,382.8870
Tangible Book Value
1,745.4040
14,292.2380
13,794.3580
1,565.1660
Total Debt
--
63.8200
176.3030
--
Share Issued
2,739.3150
2,078.2710
651.5690
201.9020
Ordinary Shares Number
2,739.3150
2,078.2710
651.5690
201.9020
12/31/2020 - 5/4/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AIM AIM ImmunoTech Inc.
0.2141
-4.80%
AZTR Azitra, Inc.
0.2679
+6.27%
NBY NovaBay Pharmaceuticals, Inc.
0.7176
+1.06%
SCPX Scorpius Holdings, Inc.
0.2817
+3.57%
WINT Windtree Therapeutics, Inc.
0.1792
-11.07%
INAB IN8bio, Inc.
0.2750
-4.11%
AEON AEON Biopharma, Inc.
0.1383
+8.05%
VINC Vincerx Pharma, Inc.
0.1040
-19.44%
BTAI BioXcel Therapeutics, Inc.
0.3400
-10.48%
REVB Revelation Biosciences, Inc.
0.2456
-23.84%